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This paper presents a functional nanoparticle-enhanced enzyme-linked immunosorbent assay (FNP-ELISA) for detection
of enterohemorrhagic Escherichia coli (EHEC) O157:H7. Immunomagnetic nanoparticles (IMMPs) conjugated with
monoclonal anti-O157:H7 antibody were used to capture E. coli O157:H7. Beacon gold nanoparticles (B-GNPs) coated
with polyclonal anti-O157:H7 and biotin single-stranded DNA (B-DNA) were then subjective to immunoreaction with
E. coli O157:H7, which was followed by streptavidin-horseradish peroxidase (Strep-HRP) conjugated with B-GNPs
based on a biotin-avidin system. The solutions containing E. coli O157:H7, IMMPs, B-GNPs, and Strep-HRP were
collected for detecting color change. The signal was significantly amplified with detection limits of 68 CFU mL−1
in PBS and 6.8 × 102 to 6.8 × 103 CFU mL−1 in the food samples. The FNP-ELISA method developed in this study
was two orders of magnitude more sensitive than immunomagnetic separation ELISA (IMS-ELISA) and four orders
of magnitude more sensitive than C-ELISA. The entire detection process of E. coli O157:H7 lasted only 3 h, and
thus FNP-ELISA is considered as a time-saving method.
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The World Health Organization estimated that about
1.8 million people worldwide die every year from diar-
rheal diseases, which are often caused by consuming
microbiologically contaminated food or by drinking water
[1]. Among the pathogens causing diarrheal diseases,
enterohemorrhagic Escherichia coli (EHEC) strains are
prominently responsible for serious foodborne outbreaks
[2,3]. In particular, E. coli O157:H7, a predominant strain
of EHEC that was first isolated and recognized as a new
type of intestinal pathogenic bacterium in the United
States in 1982 [4], has become a global public health
problem. E. coli O157:H7 outbreaks have occurred in
many developing and developed countries, causing huge
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estimated that 73,000 cases of illness and 61 deaths per
year in the United States are caused by E. coli O157:H7 [5].
The development of a rapid and reliable detection of
E. coli O157:H7 has become highly important for food
safety and public health [6]. However, traditional methods
for the detection of E. coli O157:H7 encompassing enrich-
ment, plating, culturing, enumeration, biochemical testing,
and microscopic examination can take up to 60 h, thereby
being laborious and time-consuming [7]. Polymerase chain
reactions (PCRs), including simple PCR [8], multiplex PCR
[9,10], and real-time PCR [11,12], are commonly used for
rapid detection of E. coli O157:H7, but require complex
set-ups and well-trained personnel. In addition, some
very sensitive and selective but expensive, complicated,
and time-consuming methods have been applied in the
detection of E. coli O157:H7, especially including immu-
nomagnetic separation (IMS) analysis [13], flow cytometry
[14], fluorescence in situ hybridization [15], DNA micro-
arrays [16], and several label-free methods (such as surfaced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pedance immunosensors [18,19]).
Enzyme-linked immunosorbent assay (ELISA) was re-
ported to quantitatively detect immunoglobulin G in 1971
[20]. Conventional ELISA (C-ELISA) has high reproduci-
bility and possibility for the simultaneous quantification of
a great number of assays, and is widely used to detect the
presence of substances, including bacteria [21], viruses
[22], proteins [23], and pesticides [24]. However, the
detection limit of C-ELISA to E. coli O157:H7 is only
105 to 107 CFU mL−1 [25], which is inadequate when
the infectious dose is lower than 100 cells [26].
In recent years, the emergence of nanotechnology is
opening new horizons for high detection limits in biological
fields [27-30]. Nanoparticles of various shapes, sizes, and
compositions have broad applications in microorganism
detection [31,32]. Much attention has been focused on
amplifying the detection signal using nanoparticles [33,34],
which can enhance enzyme activity [35,36]. Magnetic and
gold particles have been used to improve the detection limit
of ELISA [30,37].
In this study, we developed a functional nanoparticle-
enhanced ELISA (FNP-ELISA) using immunomagnetic
nanoparticles (IMMPs) and beacon gold nanoparticles
(B-GNPs) for detecting E. coli O157:H7. The detection
limit of E. coli O157:H7 by the developed FNP-ELISA is
much higher than that of C-ELISA or immunomagnetic
separation ELISA (IMS-ELISA), and thus FNP-ELISA
had the highest sensitivity compared to the other ELISA
methods.Materials and methods
Reagents and materials
Rabbit polyclonal anti-E. coli O157:H7 antibody and mouse
monoclonal anti-O157:H7 antibody were prepared and
purified in our laboratory. Single-stranded DNA 5′(bio-
tin)-GCTAGTGAACACAGTT-GTGTAAAAAAAAAA
(SH)-3′ was synthesized by Sangon Biotech Co., Ltd.
(China). Streptavidin-horseradish peroxidase (Strep-HRP)
and peroxidase-conjugated affinipure goat anti-rabbit
IgG (IgG-HRP) were purchased from Beijing Biosynthesis
Biological Technology Co., Ltd. (China). Bovine serum
albumin (BSA), 3,3′,5,5′- tetramethylbenzidine (TMB-
H2O2), and hydrogen tetrachloroaurate (III) trihydrate
(HAuCl4 · 3H2O, 99.9%) were purchased from Sigma-
Aldrich (USA). Dextran with a molecular weight of
40,000 (T-40) was obtained from Pharmacia (GE Health-
care, USA). Sorbitol-MacConkey agar (SMAC) and xylose-
lysine-tergitol 4 (XLT4) agar were purchased from Difco
(Becton Dickinson, USA). Ferric chloride hexahydrate
(FeCl3 · 6H2O), ferrous chloride tetrahydrate (FeCl2 ·
4H2O), and other chemicals were of analytically pure
grade or better quality. The buffer solutions were preparedin our laboratory. All aqueous solutions were prepared
using ultrapure water (18.0 MΩ/cm) as required.
Preparation of microbial samples
E. coli O157:H7 strain 35150 and E. coli K12 were obtained
from the American Type Culture Collection (ATCC, USA).
Salmonella senftenberg 50315, Shigella sonnei 51081, and
E. coli O157:Hund strain 21531 (Hund indicated that H
antigen was not determined) [38] were obtained from the
Institute of Epidemiology and Microbiology, Academy of
Preventive Medical Sciences of China. Pure cultures of
bacteria were grown in nutrient broth at 37°C for 24 h
before use. The concentrations of E. coli O157:H7, O157:
Hund, and K12 were determined by the conventional
surface plate count method using SMAC. S. senftenberg
and S. sonnei were enumerated using XLT4 agar. The
cultured bacteria were divided into two portions. The
first portion was placed in a boiling water bath for 20
min to kill the bacterial cells, and diluted to the desired
concentration with PBS (0.01 M, pH 7.4) for ELISA
detection. The second portion was not heated because
the number of living cells was counted.
Milk, vegetable, and ground beef were purchased from
a local market in Tianjin (China), and each weighed
25 g (mL) for detection. The killed E. coli O157:H7
solution was transferred into a small vial equipped with an
atomizer. The mists of E. coli O157:H7 inoculums were
sprayed onto the three samples, and the samples were
then stored at 4 ± 1°C for 1 h. Each sample was added to
0.25 mL of E. coli O157:H7 solution. The samples were
placed into sterile filter stomacher bags, and macerated in
225 mL of PBS with a stomacher blender (Bilon-8 Bilang
Co. Ltd., Beijing, China) at 200 rpm for 2 min. The hom-
ogenate was serially diluted in PBS for ELISA detection.
The negative samples that were not added to E. coli O157:
H7 solution were analyzed according to the Chinese
National Standard Method GB/T 4789.36-2008 [39].
Preparation of IMMPs
Magnetic nanoparticles (MPs) were prepared from FeCl3,
FeCl2, ammonia solution, and dextran (T-40), and oxi-
dized with NaIO4 as described previously [40]. Mouse
monoclonal anti-E. coli O157:H7 antibody (0.5 mg/mL)
was added to the oxidized MP suspension at a ratio of
0.3:1, mixed thoroughly, and incubated in the dark at 4°C
for approximately 24 h. IMMPs were washed three times
with PBS by placing a magnetic plate against the side wall
of the tubes for 5 min to concentrate the particles into the
pellets on the side walls. The supernatant was discarded
using a transferpettor. The pellets were resuspended in
1 mL of PBST (0.05% Tween-20 in 0.01 M PBS, pH
7.4). BSA was then added to a final concentration of 1%
to block any unreacted or nonspecific site. The amount
of IMMPs, incubation time, and separation time varied
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(details in Supplementary Materials).
Preparation of GNPs
GNPs were prepared according to the literature with
slight modifications [41]. In brief, 2 mL of 1% HAuCl4
was mixed with 198 mL of fresh ultrapure water. The
mixture was stirred vigorously with a magnetic agitator
while being heated in a boiling water bath for 20 min,
followed by the rapid addition of 5 mL of 1% sodium
citrate solution. After the color finally turned to full red,
the mixture was stirred again for 10 min before cooling
to room temperature. The GNP solution was filtered
through a 0.22 μm cellulose nitrate filter to remove any
floating aggregates. The prepared GNPs were character-
ized using a transmission electron microscope (TEM;
Tecnai G2 F20, FEI, Netherlands) and ultraviolet spectro-
photometer (UV 2500, Shimadzu, Japan).
Preparation of various B-GNPs
B-GNPs were prepared following a previously reported
procedure [42,43] with slight modifications. Rabbit poly-
clonal anti-E. coli O157:H7 antibody (7 μg) was added to
1 mL of pH-adjusted GNP solution (pH 8.2) and incu-
bated at room temperature for 30 min. The mixture was
added with 30 μL of different concentrations of B-DNA,
and incubated in the dark at 4°C for more than 16 h.
Approximately 100 μL of 1% sodium chloride solution
was then added to the mixture, and incubated at 4°C
for 3 h. BSA was added to a final concentration of 1%
to block any unreacted or nonspecific site. The prepared
B-GNP solution was centrifuged at 20,000 g for 1 h at 4°C.
The final deposition was suspended in 0.5 mL of storage
buffer (PBS, 0.01 M, pH 7.4, 1% BSA, 0.02% NaN3) and
stored at 4°C.
C-ELISA
Mouse monoclonal anti-E. coli O157:H7 antibody (100 μL
of 5 mg L−1) was added to a 96-well plate and incubated
at 37°C for 2 h. The plate was rinsed with PBST (0.05%
Tween-20 in 0.01 M PBS, pH 7.4) three times to remove
unbound antibodies, followed by the addition of 100 μL of
PBS-BSA (1% BSA in 0.01 M PBS, pH 7.4) and incubation
at 4°C for 12 h. Different concentrations of E. coli O157:
H7 (100 μL) were added to each well and reacted at 37°C
for 1 h. After rinsing three times, 100 μL of 5 mg L−1
rabbit polyclonal anti-E. coli O157:H7 antibody was added
to the plate incubated at 37°C for 1 h. Subsequently, 100
μL of 0.02 mg L−1 IgG-HRP was added to the plate and
incubated for 1 h at 37°C. The plate was rinsed three times
to remove unbound IgG-HRP. Finally, 100 μL of TMB-
H2O2 solution was added to each well and incubated at
37°C for 15 min. The reaction was terminated using 100μL of 0.5 M sulfuric acid, and the absorbance at 450 nm
was measured using a microplate reader.
IMS-ELISA
E. coli O157:H7 was separated using IMMPs according
to the previous procedure in Supplementary Materials,
and the particle-bacteria complex (100 μL) was finally
resuspended. Rabbit polyclonal anti-O157:H7 antibody
(100 μL of 5 mg L−1) was added to the complex, and
incubated at room temperature for 30 min. The unbound
antibody was removed by the magnetic plate method. The
particle-bacteria-antibody complex was resuspended using
100 μL of 0.02 mg L−1 IgG-HRP, and incubated for 1 h at
37°C. The complex was resuspended and transferred to a
96-well plate after excess IgG-HRP was removed by the
magnetic plate method. Finally, TMB-H2O2 and sulfuric
acid were subsequently added, and the plate was read at
450 nm using a microplate reader.
FNP-ELISA
IMMPs (10 μL) were added to 1 mL of E. coli O157:H7
suspension at 106 CFU mL−1 in a 1.5 mL Eppendorf
tube. The tube was carefully inverted several times and
incubated at room temperature for 10 min. Approximately
100 μL of the complex of E. coli O157:H7 and IMMPs
was obtained by the magnetic plate method. Various B-
GNPs (100 μL) were added to 100 μL of the complex, and
incubated at room temperature for 30 min. The unbound
B-GNPs were removed by the magnetic plate method, and
the complex was rinsed three times with PBST. Subse-
quently, 100 μL of Strep-HRP (0.01 mg L−1) solution was
added to the Eppendorf tube and incubated at 37°C for 1
h. The unbound Strep-HRP was removed by the magnetic
plate method. The final complex was washed three
times with PBST by the magnetic plate method, and
resuspended in 100 μL of PBS. The suspension was
then transferred to a 96-well plate. Finally, TMB-H2O2
and sulfuric acid were subsequently added, and the
plate was read at 450 nm using a microplate reader.
Experimental replicates and statistical methods
All the experiments were done with at least biological
replicates, and the values were expressed as mean ± stand-
ard deviation. A conventionally used positive control to
negative control (P/N) value ≥2.1 was considered positive
in the three ELISA methods [44]. When needed, paired
Student’s t-test was performed to determine statistically




We prepared MPs that were roughly spherical in shape
with diameters ranging from 40–60 nm, and contained an
Figure 1 Typical TEM images of GNPs.
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We also prepared IMMPs, and the recovery of IMMPs in-
creased with increasing amount of IMMPs and incubation
time. Relatively high recovery was obtained with 10 μL
of IMMPS (Additional file 1: Table S1) and 10 min of incu-
bation (Additional file 1: Table S2). The optimal time for
separation was 2 min (Additional file 1: Table S3). ThisFigure 2 Flow chart of FNP-ELISA. Preparation of IMMPs and B-GNPs (pa
target cells (step 1), conjugation of B-GNPs (step 2), removal of free B-GNPs (s
(step 5); and FNP-ELISA detection (part C).finding was supported by a previous study, which showed
that target cells can be separated from samples using MPs
coupled with aptamer/nucleic acid/antibody [45,46].
Properties of B-GNPs
We successfully prepared GNPs with an average diameter
of approximately 18 nm as measured by TEM (Figure 1).
The maximum peak of GNP solution was 518 nm as
determined by UV scanning. We prepared a new type of
GNP, namely, B-GNPs, which could target E. coli O157:
H7 through the polyclonal antibody and amplify signals
through the biotin-avidin Strep-HRP system.
Experimental design for FNP-ELISA
In this study, a novel ELISA method namely FNP-ELISA
was established to detect E. coli O157:H7, in comparison
with C-ELISA, and IMS-ELISA. A schematic diagram
illustrating the detection of E. coli O157:H7 by FNP-
ELISA is presented in Figure 2.
First, functional monoclonal anti-E. coli O157:H7-con-
jugated IMMPs and polyclonal anti-E. coli O157:H7
antibody and B-GNPs are prepared (A). Second, IMMPs
are mixed with a sample to target E. coli O157:H7, and
the O157:H7-IMMP complex is separated using the
magnetic plate method (step 1, B). Third, B-GNPs are
added to target E. coli O157:H7 in the E. coli O157:H7-
IMMP complex (step 2, B), and the unbound B-GNPs
are removed by the magnetic plate method (step 3, B).rt A); (part B) comprises five steps, namely, magnetic separation of
tep 3), conjugation of Strep-HRP (step 4), and removal of free Strep-HRP
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anti-E. coli O157:H7 (step 4, B), and unbound Strep-HRP
is removed by the magnetic plate method. Finally, the
remaining routine ELISA steps are completed (C).Optimized amounts of B-DNA, Strep-HRP and
B-GNPs for FNP-ELISA
The optimal amounts of B-DNA, Strep-HRP, and B-GNPs
for FNP-ELISA were investigated (Figure 3). To obtain an
optimized concentration of B-DNA, we added 100 μL of
different B-GNPs conjugated with different concentrations
of B-DNA to the complex of E. coli O157:H7 and IMMPs
after separating E. coli O157:H7. The aforementioned
procedure was then repeated.
The optimal volume of B-GNPs was determined by add-
ing different volumes of the optimized B-GNPs to the
complex of E. coli O157:H7 and IMMPs after separating
E. coli O157:H7. The detection procedure was then oper-
ated as above.Figure 3 Optimal amounts of B-DNA, Strep-HRP, and B-GNPs. (a) Opti
(b) Optimization of the B-GNP volume. (c) Strep-HRP volume optimization graThe optimized volume of Strep-HRP was determined
when the optimized volume of B-GNPs was applied in
the procedure. After optimizing the parameters, various
concentrations of E. coli O157:H7 were detected in PBS
using FNP-ELISA. The negative samples included K12, S.
senftenberg, and S. sonnei in FNP-ELISA. This method
was then used to determine the concentration of E. coli
O157:H7 in the milk, vegetable, and ground beef samples.
We found that the FNP-ELISA signal increased with
increasing B-DNA concentration (Figure 3a), and the
optimal concentration of B-DNA was 40 μmol L−1. This
finding was also observed in a previous study, which
reported that excess B-DNA molecules cause excessive
HRP molecules to bind with GNPs, posing steric hin-
drance to hamper antigens from access to antibodies on
GNPs [47].
The signal of FNP-ELISA was strongly dependent on
the amount of B-GNPs. The ELISA signal increased as
the amount of B-GNPs increased, and reached a plateau
at 100 μL (Figure 3b). Thus, we used 100 μL of B-GNPsmization graph of the B-DNA concentration in the preparation of B-GNPs.
ph.
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Strep-HRP was also obtained at 100 μL (Figure 3c).
Comparison of FNP-ELISA to C-ELISA and IMS-ELISA
Functional nanoparticles were used to improve the sensitiv-
ity of ELISA, and the results were compared simultan-
eously. The blank, positive, and negative controls were PBS,
E. coli O157:H7 (106 CFU mL−1), and E. coli O157:Hund
(106 CFU mL−1), respectively. These controls were included
on each plate in the experiments.
The surface plate counts showed that the concentra-
tions of the test solutions of E. coli O157:H7, E. coli
O157: Hund, K12, S. senftenberg, and S. sonnei were
6.8 × 10°–6.8 × 108 CFU mL−1, 6.1 × 106 CFU mL−1,
7.1 × 10°–7.1 × 108 CFU mL−1, 8.1 × 10°–8.1 × 108 CFU
mL−1, and 2.3 × 10°–2.3 × 108 CFU mL−1, respectively.
The detection limits of C-ELISA, IMS-ELISA, and FNP-
ELISA were 6.8 × 105 (n = 3, 1.8 ≤ RSD ≤ 4.7), 6.8 × 103
(n = 3, 0.6 ≤ RSD ≤ 5.2), and 68 CFU mL−1 (n = 3, 0.3 ≤
RSD ≤ 4.7) in PBS, respectively (Figure 4). The three
ELISA methods had high reproducibility, and all RSD
values were lower than 10.
The specificity of the three ELISA methods was
dependent on the quality of the antibody. The specificity
of the rabbit polyclonal anti-E. coli O157:H7 antibody
and mouse monoclonal anti-E. coli O157:H7 antibody
was tested using 61 bacteria, and false negative and false
positive results were not observed (data not shown).
E. coli O157:H7 is a common intestinal pathogen, so
S. senftenberg and S. sonnei, which are also common
intestinal pathogens, were selected as negative samples.
E. coli K12, which represented E. coli, was anotherFigure 4 ELISA Detection sensitivity. The detection limits of C-ELISA, IMS
(0.6≤ RSD≤ 5.2), and 6.8 × 101 CFU mL−1 (0.3 ≤ RSD ≤ 4.7), respectively (n =negative sample. The P/N values of the negative signals
were all significantly lower than 2.1 (Figure 4), which
shows that FNP-ELISA had high specificity.
E. coli O157:H7 was not detected in the raw vegetable,
milk, and ground beef samples using GB/T method
4789.36-2008. The detection limits of FNP-ELISA were
6.8 × 102 CFU mL−1 in vegetable and milk, and 6.8 × 103
CFU mL−1 in ground beef. The reduction in sensitiv-
ities may be attributed to the loss of some functional
nanoparticles and targeting bacteria in the food residues,
particularly grease foods.Concluding remarks
Multiple ultrasensitive methods for detecting E. coli
O157:H7 have been reported [48,49], but they usually
require expensive equipment or skilled personnel and
thus have difficulty in wide use. C-ELISA has been
widely established to detect microorganisms, proteins,
pesticides, and heavy metals because of its simplicity and
low cost, but its application is limited because of its low
detection limit. Data presented here indicated that FNP-
ELISA had a high sensitivity in detecting E. coli O157:
H7, with a detection limit of 68 CFU mL−1 in PBS and
6.8 × 102 to 103 CFU mL−1 in foods. The detection limit
of FNP-ELISA was about two or four orders of magni-
tude lower than that of IMS-ELISA or C-ELISA, respect-
ively. Moreover, the total analysis time of FNP-ELISA
was only approximately 3 h. Therefore, FNP-ELISA may
be used for detection of E. coli O157:H7 in foods, and
also for other microorganisms if appropriate antibodies
are available.-ELISA, and FNP-ELISA were 6.8 × 105 (1.8 ≤ RSD ≤ 4.7), 6.8 × 103
3).
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Additional file 1: Table S1. Effect of amount of IMMPs on recovery.
Table S2 Effect of incubation time on recovery. Table S3 Effect of
separation on recovery. Figure S1 Transmission electron micrograph of
IMMPs. The electron dense core was about 5 nm.
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